To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 332,930 shares, the number of shares held decreased 28.7% compared to the previous period and now represents 0.63% of the total position.
      12Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Iambic Therapeutics by 73,434 shares, the number of shares held increased 5.44% compared to the previous period and now represents 0.88% of the total position.
      130Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Kymera Therapeutics, Inc. by 10,174 shares, the number of shares held increased 9.75% compared to the previous period and now represents 0.7% of the total position.
      126Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 11,358 shares, the number of shares held increased 0.7% compared to the previous period and now represents 1.04% of the total position.
      86Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 17,682 shares, the number of shares held increased 0.7% compared to the previous period and now represents 7.54% of the total position.
      73Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Illumina by 9,889 shares, the number of shares held increased 2.58% compared to the previous period and now represents 4.27% of the total position.
      188Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Absci Corporation. by 75,912 shares, the number of shares held increased 0.7% compared to the previous period and now represents 5.09% of the total position.
      29Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 14,189 shares, the number of shares held decreased 1.28% compared to the previous period and now represents 4.51% of the total position.
      17Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 468 shares, the number of shares held increased 0.69% compared to the previous period and now represents 4.61% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 21,528 shares, the number of shares held increased 0.7% compared to the previous period and now represents 3.86% of the total position.
      152Comment
      Report
       
       
       
       

      Most Discussed